 | • レポートコード：GIR-105X13447 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ペンブロリズマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ペンブロリズマブの種類別市場規模（50mg注射、100mg注射）、用途別市場規模（進行性黒色腫、頭頸部扁平上皮癌（HNSCC）、切除不能・転移性固形腫瘍、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ペンブロリズマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Merck ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：50mg注射、100mg注射 ・用途別分析2016年-2026年：進行性黒色腫、頭頸部扁平上皮癌（HNSCC）、切除不能・転移性固形腫瘍、その他 ・ペンブロリズマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ペンブロリズマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ペンブロリズマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ペンブロリズマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ペンブロリズマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Pembrolizumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Pembrolizumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Pembrolizumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Pembrolizumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
50mg Injection
100mg Injection
Market segment by Application can be divided into
Advanced Melanoma
Head and Neck Squamous Cell Carcinoma (HNSCC)
Unresectable or Metastatic Solid Tumor
Other
The key market players for global Pembrolizumab market are listed below:
Merck
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Pembrolizumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pembrolizumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 50mg Injection
1.2.3 100mg Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Pembrolizumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Advanced Melanoma
1.3.3 Head and Neck Squamous Cell Carcinoma (HNSCC)
1.3.4 Unresectable or Metastatic Solid Tumor
1.3.5 Other
1.4 Global Pembrolizumab Market Size & Forecast
1.4.1 Global Pembrolizumab Sales in Value (2016-2026))
1.4.2 Global Pembrolizumab Sales in Volume (2016-2026)
1.4.3 Global Pembrolizumab Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Pembrolizumab Production Capacity Analysis
1.5.1 Global Pembrolizumab Total Production Capacity (2016-2026)
1.5.2 Global Pembrolizumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pembrolizumab Market Drivers
1.6.2 Pembrolizumab Market Restraints
1.6.3 Pembrolizumab Trends Analysis
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Pembrolizumab Product and Services
2.1.4 Merck Pembrolizumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Pembrolizumab Sales by Manufacturer
3.1 Global Pembrolizumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Pembrolizumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Pembrolizumab
3.4 Market Concentration Rate
3.4.1 Top 3 Pembrolizumab Manufacturer Market Share
3.4.2 Top 6 Pembrolizumab Manufacturer Market Share
3.5 Global Pembrolizumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Pembrolizumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pembrolizumab Market Size by Region
4.1.1 Global Pembrolizumab Sales in Volume by Region (2016-2026)
4.1.2 Global Pembrolizumab Revenue by Region (2016-2026)
4.2 North America Pembrolizumab Revenue (2016-2026)
4.3 Europe Pembrolizumab Revenue (2016-2026)
4.4 Asia-Pacific Pembrolizumab Revenue (2016-2026)
4.5 South America Pembrolizumab Revenue (2016-2026)
4.6 Middle East and Africa Pembrolizumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Pembrolizumab Sales in Volume by Type (2016-2026)
5.2 Global Pembrolizumab Revenue by Type (2016-2026)
5.3 Global Pembrolizumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Pembrolizumab Sales in Volume by Application (2016-2026)
6.2 Global Pembrolizumab Revenue by Application (2016-2026)
6.3 Global Pembrolizumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Pembrolizumab Sales by Type (2016-2026)
7.2 North America Pembrolizumab Sales by Application (2016-2026)
7.3 North America Pembrolizumab Market Size by Country
7.3.1 North America Pembrolizumab Sales in Volume by Country (2016-2026)
7.3.2 North America Pembrolizumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Pembrolizumab Sales by Type (2016-2026)
8.2 Europe Pembrolizumab Sales by Application (2016-2026)
8.3 Europe Pembrolizumab Market Size by Country
8.3.1 Europe Pembrolizumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Pembrolizumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Pembrolizumab Sales by Type (2016-2026)
9.2 Asia-Pacific Pembrolizumab Sales by Application (2016-2026)
9.3 Asia-Pacific Pembrolizumab Market Size by Region
9.3.1 Asia-Pacific Pembrolizumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Pembrolizumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Pembrolizumab Sales by Type (2016-2026)
10.2 South America Pembrolizumab Sales by Application (2016-2026)
10.3 South America Pembrolizumab Market Size by Country
10.3.1 South America Pembrolizumab Sales in Volume by Country (2016-2026)
10.3.2 South America Pembrolizumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pembrolizumab Sales by Type (2016-2026)
11.2 Middle East & Africa Pembrolizumab Sales by Application (2016-2026)
11.3 Middle East & Africa Pembrolizumab Market Size by Country
11.3.1 Middle East & Africa Pembrolizumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Pembrolizumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Pembrolizumab Typical Distributors
12.3 Pembrolizumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Pembrolizumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Pembrolizumab Revenue by Application, (USD Million), 2021-2026
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Pembrolizumab Product and Services
Table 6. Merck Pembrolizumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Pembrolizumab Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 8. Global Pembrolizumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Pembrolizumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Pembrolizumab Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 11. Head Office and Pembrolizumab Production Site of Key Manufacturer
Table 12. Global Pembrolizumab Sales by Region (2016-2021e) & (K Pcs)
Table 13. Global Pembrolizumab Sales by Region (2021-2026) & (K Pcs)
Table 14. Global Pembrolizumab Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Pembrolizumab Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Pembrolizumab Sales by Type (2016-2021e) & (K Pcs)
Table 17. Global Pembrolizumab Sales by Type (2021-2026) & (K Pcs)
Table 18. Global Pembrolizumab Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Pembrolizumab Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Pembrolizumab Price by Type (2016-2021e) & (USD/Pcs)
Table 21. Global Pembrolizumab Price by Type (2021-2026) & (USD/Pcs)
Table 22. Global Pembrolizumab Sales by Application (2016-2021e) & (K Pcs)
Table 23. Global Pembrolizumab Sales by Application (2021-2026) & (K Pcs)
Table 24. Global Pembrolizumab Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Pembrolizumab Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Pembrolizumab Price by Application (2016-2021e) & (USD/Pcs)
Table 27. Global Pembrolizumab Price by Application (2021-2026) & (USD/Pcs)
Table 28. North America Pembrolizumab Sales by Country (2016-2021e) & (K Pcs)
Table 29. North America Pembrolizumab Sales by Country (2021-2026) & (K Pcs)
Table 30. North America Pembrolizumab Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Pembrolizumab Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Pembrolizumab Sales by Type (2016-2021e) & (K Pcs)
Table 33. North America Pembrolizumab Sales by Type (2021-2026) & (K Pcs)
Table 34. North America Pembrolizumab Sales by Application (2016-2021e) & (K Pcs)
Table 35. North America Pembrolizumab Sales by Application (2021-2026) & (K Pcs)
Table 36. Europe Pembrolizumab Sales by Country (2016-2021e) & (K Pcs)
Table 37. Europe Pembrolizumab Sales by Country (2021-2026) & (K Pcs)
Table 38. Europe Pembrolizumab Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Pembrolizumab Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Pembrolizumab Sales by Type (2016-2021e) & (K Pcs)
Table 41. Europe Pembrolizumab Sales by Type (2021-2026) & (K Pcs)
Table 42. Europe Pembrolizumab Sales by Application (2016-2021e) & (K Pcs)
Table 43. Europe Pembrolizumab Sales by Application (2021-2026) & (K Pcs)
Table 44. Asia-Pacific Pembrolizumab Sales by Region (2016-2021e) & (K Pcs)
Table 45. Asia-Pacific Pembrolizumab Sales by Region (2021-2026) & (K Pcs)
Table 46. Asia-Pacific Pembrolizumab Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Pembrolizumab Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Pembrolizumab Sales by Type (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Pembrolizumab Sales by Type (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Pembrolizumab Sales by Application (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific Pembrolizumab Sales by Application (2021-2026) & (K Pcs)
Table 52. South America Pembrolizumab Sales by Country (2016-2021e) & (K Pcs)
Table 53. South America Pembrolizumab Sales by Country (2021-2026) & (K Pcs)
Table 54. South America Pembrolizumab Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Pembrolizumab Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Pembrolizumab Sales by Type (2016-2021e) & (K Pcs)
Table 57. South America Pembrolizumab Sales by Type (2021-2026) & (K Pcs)
Table 58. South America Pembrolizumab Sales by Application (2016-2021e) & (K Pcs)
Table 59. South America Pembrolizumab Sales by Application (2021-2026) & (K Pcs)
Table 60. Middle East & Africa Pembrolizumab Sales by Country (2016-2021e) & (K Pcs)
Table 61. Middle East & Africa Pembrolizumab Sales by Country (2021-2026) & (K Pcs)
Table 62. Middle East & Africa Pembrolizumab Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Pembrolizumab Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Pembrolizumab Sales by Type (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Pembrolizumab Sales by Type (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Pembrolizumab Sales by Application (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa Pembrolizumab Sales by Application (2021-2026) & (K Pcs)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Pembrolizumab Typical Distributors
Table 71. Pembrolizumab Typical Customers
List of Figures
Figure 1. Pembrolizumab Picture
Figure 2. Global Pembrolizumab Sales Market Share by Type in 2020
Figure 3. 50mg Injection
Figure 4. 100mg Injection
Figure 5. Global Pembrolizumab Sales Market Share by Application in 2020
Figure 6. Advanced Melanoma
Figure 7. Head and Neck Squamous Cell Carcinoma (HNSCC)
Figure 8. Unresectable or Metastatic Solid Tumor
Figure 9. Other
Figure 10. Global Pembrolizumab Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 11. Global Pembrolizumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Pembrolizumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Pembrolizumab Sales (2016-2026) & (K Pcs)
Figure 32. Global Pembrolizumab Production Capacity (2016-2026) & (K Pcs)
Figure 33. Global Pembrolizumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Pembrolizumab Market Drivers
Figure 35. Pembrolizumab Market Restraints
Figure 36. Pembrolizumab Market Trends
Figure 37. Global Pembrolizumab Sales Market Share by Manufacturer in 2020
Figure 38. Global Pembrolizumab Revenue Market Share by Manufacturer in 2020
Figure 39. Pembrolizumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Pembrolizumab Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Pembrolizumab Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Pembrolizumab Sales Market Share by Region (2016-2026)
Figure 43. Global Pembrolizumab Revenue Market Share by Region (2016-2026)
Figure 44. North America Pembrolizumab Revenue (2016-2026) & (USD Million)
Figure 45. Europe Pembrolizumab Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Pembrolizumab Revenue (2016-2026) & (USD Million)
Figure 47. South America Pembrolizumab Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Pembrolizumab Revenue (2016-2026) & (USD Million)
Figure 49. Global Pembrolizumab Sales Market Share by Type (2016-2026)
Figure 50. Global Pembrolizumab Revenue Market Share by Type (2016-2026)
Figure 51. Global Pembrolizumab Price by Type (2016-2026) & (USD/Pcs)
Figure 52. Global Pembrolizumab Sales Market Share by Application (2016-2026)
Figure 53. Global Pembrolizumab Revenue Market Share by Application (2016-2026)
Figure 54. Global Pembrolizumab Price by Application (2016-2026) & (USD/Pcs)
Figure 55. North America Pembrolizumab Sales Market Share by Country (2016-2026)
Figure 56. North America Pembrolizumab Revenue Market Share by Country (2016-2026)
Figure 57. North America Pembrolizumab Sales Market Share by Type (2016-2026)
Figure 58. North America Pembrolizumab Sales Market Share by Application (2016-2026)
Figure 59. Europe Pembrolizumab Sales Market Share by Country (2016-2026)
Figure 60. Europe Pembrolizumab Revenue Market Share by Country (2016-2026)
Figure 61. Europe Pembrolizumab Sales Market Share by Type (2016-2026)
Figure 62. Europe Pembrolizumab Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Pembrolizumab Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Pembrolizumab Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Pembrolizumab Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Pembrolizumab Sales Market Share by Application (2016-2026)
Figure 67. South America Pembrolizumab Sales Market Share by Country (2016-2026)
Figure 68. South America Pembrolizumab Revenue Market Share by Country (2016-2026)
Figure 69. South America Pembrolizumab Sales Market Share by Type (2016-2026)
Figure 70. South America Pembrolizumab Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Pembrolizumab Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Pembrolizumab Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Pembrolizumab Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Pembrolizumab Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source
世界のニボルマブ市場 2021：企業別、地域別、種類・用途別 The Nivolumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent d…- 世界の転移性骨腫瘍治療市場 2021：企業別、地域別、種類・用途別 The Metastatic Bone Tumor Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…
- 世界のアザシチジン注射市場 2021：企業別、地域別、種類・用途別 The Azacitidine Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
- 世界の樹状細胞・腫瘍細胞がんワクチン市場 2021：企業別、地域別、種類・用途別 The Dendritic Cell and Tumor Cell Cancer Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 世界の皮下注射免疫グロブリン市場 2021：企業別、地域別、種類・用途別 The Subcutaneous Injection Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…